Information Journal Paper
APA:
Copy. (2017). A PTK7-targeted antibody-drug conjugate reduces tumor-initiating cells and induces sustained tumor regressions. SCIENCE TRANSLATIONAL MEDICINE, 9(372), 0-0. SID. https://sid.ir/paper/758262/en
Vancouver:
Copy. A PTK7-targeted antibody-drug conjugate reduces tumor-initiating cells and induces sustained tumor regressions. SCIENCE TRANSLATIONAL MEDICINE[Internet]. 2017;9(372):0-0. Available from: https://sid.ir/paper/758262/en
IEEE:
Copy, “A PTK7-targeted antibody-drug conjugate reduces tumor-initiating cells and induces sustained tumor regressions,” SCIENCE TRANSLATIONAL MEDICINE, vol. 9, no. 372, pp. 0–0, 2017, [Online]. Available: https://sid.ir/paper/758262/en